Clinical Trial Update: Sugammadex Versus Neostigmine for Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sugammadex to neostigmine for prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• BRIDION (Sugammadex)
• Neostigmine (neostigmine)

Snippet

Sponsor: KK Women's and Children's Hospital | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED